Skip to topic
    ← Back to course topics

    Health, disease and the development of medicines — Edexcel GCSE Combined Science

    Test yourself on Health, disease and the development of medicines with PEARSON EDEXCEL GCSE practice questions.

    Start free

    7 days Premium · Then free forever · No card, no charge

    Health, disease and the development of medicines explained

    This topic covers the role of antibiotics in treating bacterial infections and the multi-stage process required to develop new medicines.

    Read the full explanation

    It details the necessity of preclinical and clinical testing to ensure safety and efficacy before a new medicine is approved for use.

    Read the Health, disease and the development of medicines study guideFull revision notes for Edexcel GCSE Combined Science

    What to demonstrate

    1. Antibiotics inhibit cell processes in bacteria but not in the host organism
    2. Antibiotics are ineffective against viral infections
    3. The development process includes discovery, development, preclinical testing, and clinical testing
    Show all 5 objectives
    1. Preclinical testing involves laboratory studies on cells, tissues, or live animals
    2. Clinical testing involves trials on healthy volunteers and patients to determine safety, dosage, and efficacy

    Health, disease and the development of medicines exam tips

    Topic Overview

    This topic explores the relationship between health and disease, focusing on how communicable and non-communicable diseases affect the human body. You'll learn about pathogens (bacteria, viruses, fungi, protists) and how they cause infectious diseases like cholera, tuberculosis, HIV/AIDS, and malaria. The topic also covers the body's defence mechanisms, including physical barriers (skin, mucus), chemical defences (stomach acid, lysozyme), and the immune system's specific response involving white blood cells, antibodies, and memory cells. Understanding these concepts is crucial for grasping how vaccines, antibiotics, and other medicines work to prevent and treat diseases.

    The development of medicines is a key part of this topic, covering the stages from drug discovery to clinical trials. You'll study how drugs are tested for efficacy, toxicity, and dosage using computer models, human cells, animals, and human volunteers. The importance of double-blind trials and placebos is emphasised to ensure reliable results. This topic also links to wider issues like antibiotic resistance, which arises from overuse and misuse of antibiotics, and the need for new medicines. By the end, you should appreciate how science and medicine work together to improve global health and the ethical considerations involved in drug testing.

    This topic fits into the broader Combined Science curriculum by connecting with cell biology (pathogen structure), genetics (inherited diseases), and ecology (disease transmission). It also builds a foundation for understanding lifestyle factors like diet, exercise, and smoking that contribute to non-communicable diseases such as cardiovascular disease and type 2 diabetes. Mastering this content will help you answer questions about health campaigns, vaccination programmes, and the role of science in society.

    Key Concepts
    • →Pathogens are microorganisms that cause infectious diseases; they include bacteria, viruses, fungi, and protists. Each type has different structures and modes of action (e.g., viruses reproduce inside host cells, bacteria produce toxins).
    • →The immune system has two lines of defence: non-specific (physical and chemical barriers, phagocytosis) and specific (lymphocyte response producing antibodies and memory cells). Vaccination exploits the specific response to create immunity without causing disease.
    • →Antibiotics kill or inhibit bacteria, not viruses. Overuse leads to antibiotic resistance via natural selection – resistant bacteria survive and reproduce, making infections harder to treat. This is a major global health concern.
    • →Drug development involves preclinical testing (computer models, cell cultures, animal testing) followed by clinical trials (Phase I: healthy volunteers for safety; Phase II: patients for efficacy; Phase III: large-scale double-blind trials with placebos). Ethical and safety regulations are strict.
    • →Non-communicable diseases (e.g., cardiovascular disease, cancer, diabetes) are not infectious and often linked to lifestyle factors (diet, exercise, smoking, alcohol). They can interact with communicable diseases (e.g., a weakened immune system from HIV increases susceptibility to other infections).
    Marking Points
    • Antibiotics inhibit cell processes in bacteria but not in the host organism
    • Antibiotics are ineffective against viral infections
    • The development process includes discovery, development, preclinical testing, and clinical testing
    • Preclinical testing involves laboratory studies on cells, tissues, or live animals
    • Clinical testing involves trials on healthy volunteers and patients to determine safety, dosage, and efficacy
    Examiner Tips
    • 💡Ensure you can clearly explain why antibiotics do not work on viruses
    • 💡Be prepared to describe the sequence of medicine development in the correct order
    • 💡Understand the difference between preclinical (lab/animal) and clinical (human) testing
    • 💡Use precise terminology when describing the stages of testing
    • 💡When explaining how the immune system responds to a pathogen, use the correct sequence: phagocytosis (non-specific) → lymphocyte activation → antibody production → memory cells. Mention that antibodies are specific to the antigen and that memory cells provide long-term immunity.
    • 💡For questions on drug development, always include the three phases of clinical trials and the purpose of each. Use terms like 'double-blind trial' and 'placebo' to show understanding of bias reduction. State that ethical approval is needed before trials.
    • 💡When discussing antibiotic resistance, link it to natural selection: bacteria with resistance genes survive antibiotic treatment, reproduce, and pass on the gene. Mention that overuse and incomplete courses of antibiotics accelerate this process.
    Common Mistakes
    • Confusing antibiotics with antivirals or vaccines
    • Failing to distinguish between preclinical and clinical testing stages
    • Assuming antibiotics can kill viruses
    • Misunderstanding the purpose of clinical trials (e.g., focusing only on efficacy and ignoring safety/dosage)
    • Misconception: Antibiotics can cure viral infections like the common cold. Correction: Antibiotics only work against bacteria, not viruses. Using them for viral infections contributes to antibiotic resistance and is ineffective.
    • Misconception: Vaccines give you the disease they protect against. Correction: Vaccines contain weakened or dead pathogens, or just antigens, which stimulate the immune system without causing illness. Some mild side effects (e.g., sore arm, slight fever) are normal and not the disease itself.
    • Misconception: If a drug passes animal testing, it is safe for humans. Correction: Animal testing is a necessary step, but human physiology differs; drugs can have unexpected side effects in humans. That's why clinical trials are essential.
    Frequently Asked Questions
    What is the difference between communicable and non-communicable diseases?
    Communicable diseases are infectious and can be passed from person to person (or from animals to humans) via pathogens like bacteria or viruses. Examples include flu, COVID-19, and malaria. Non-communicable diseases are not infectious and cannot be transmitted; they often develop over time due to lifestyle factors, genetics, or environmental exposures. Examples include heart disease, type 2 diabetes, and most cancers.
    How do vaccines work to prevent disease?
    Vaccines contain harmless versions of a pathogen (dead, weakened, or just its antigens). When injected, they stimulate the immune system to produce specific antibodies and memory cells without causing illness. If the real pathogen later infects the body, the memory cells quickly trigger antibody production, destroying the pathogen before symptoms develop. This is called active immunity.
    Why do antibiotics not work against viruses?
    Antibiotics target bacterial structures or processes, such as cell wall synthesis or protein production, that are different from those in human cells. Viruses are not cells; they lack these structures and instead hijack host cell machinery to replicate. Therefore, antibiotics cannot affect viruses. Antiviral drugs are different and target specific viral enzymes or entry points.
    What are the stages of drug testing before a medicine can be approved?
    First, drugs are tested in the lab using computer models and human cells (in vitro) to check for toxicity and efficacy. Then, animal testing (in vivo) is done to see how the drug affects a living organism. If successful, clinical trials on humans begin: Phase I tests safety and dosage on healthy volunteers; Phase II tests efficacy on a small group of patients; Phase III involves large-scale double-blind trials with placebos to confirm effectiveness and monitor side effects. Only after all phases pass regulatory approval can the drug be marketed.
    How does antibiotic resistance develop and why is it a problem?
    Antibiotic resistance develops through natural selection. When antibiotics are used, most bacteria are killed, but some with resistant genes survive. These resistant bacteria reproduce, passing on the resistance gene. Overuse and misuse of antibiotics (e.g., not finishing a course, using them for viral infections) accelerate this process. It's a problem because common infections become harder to treat, leading to longer illnesses, more hospital stays, and increased risk of death. New antibiotics are urgently needed.
    What is the role of white blood cells in the immune system?
    White blood cells are key to fighting pathogens. Phagocytes (a type of white blood cell) engulf and digest pathogens in a process called phagocytosis – this is a non-specific defence. Lymphocytes (another type) produce specific antibodies that bind to antigens on pathogens, marking them for destruction. Some lymphocytes become memory cells that remain in the body, providing long-term immunity if the same pathogen attacks again.